EHA 2017 | Two is better than one: drug synergy in relapsed/refractory NHL

Paul A. Hamlin

Press brief by Paul A. Hamlin, MD from the Memorial Sloan Kettering Cancer Centre, New York, NY, USA at the European Hematology Association (EHA) 2017 meeting, held in Madrid, Spain.

Share this video  
Similar topics